UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)

Phase 2

Withdrawn

Conditions: Non-small Cell Lung Cancer, Stage III

First Posted Date: 2009-05-19

Last Posted Date: 2015-04-27

Lead Sponsor: University of Rochester

Registration Number: NCT00903942

Locations: 🇺🇸
University of Rochester, Medical Center, Rochester, New York, United States

Psychosocial Treatment for Women With Depression and Pain

Not Applicable

Completed

Conditions: Depression
Pelvic Pain

Interventions: Behavioral: Interpersonal Therapy for Pain (IPT-P)
Behavioral: Enhanced Support and Connection to Counseling

First Posted Date: 2009-05-11

Last Posted Date: 2014-03-14

Lead Sponsor: University of Rochester

Target Recruit Count: 60

Registration Number: NCT00895999

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Self Management in Urinary Catheter Users

Phase 2

Completed

Conditions: Urinary Retention
Neurogenic Bladder

Interventions: Behavioral: Self-management of urinary catheter

First Posted Date: 2009-04-17

Last Posted Date: 2012-09-18

Lead Sponsor: University of Rochester

Target Recruit Count: 202

Registration Number: NCT00883220

Locations: 🇺🇸
Center for Home Care Policy & Research, Visiting Nurse Service of New York, New York City, New York, United States
🇺🇸
Urinary of Rochester, Rochester, New York, United States

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Phase 3

Terminated

Conditions: Pulmonary Embolism
Venous Thromboembolism

Interventions: Drug: dalteparin injection

First Posted Date: 2009-04-07

Last Posted Date: 2015-11-24

Lead Sponsor: University of Rochester

Target Recruit Count: 218

Registration Number: NCT00876915

Locations: 🇺🇸
University of California, Davis, Sacramento, California, United States
🇺🇸
Rochester General Hospital, Rochester, New York, United States
🇺🇸
Duke University School of Medicine, Durham, North Carolina, United States

and more 4 locations

A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Decitabine
Drug: Rapamycin

First Posted Date: 2009-03-16

Last Posted Date: 2012-10-10

Lead Sponsor: University of Rochester

Target Recruit Count: 13

Registration Number: NCT00861874

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Effects of Pioglitazone on Platelet Function

Phase 2

Completed

Conditions: Platelet Function
Diabetes
Healthy

Interventions: Drug: Aspirin
Drug: Pioglitazone

First Posted Date: 2009-03-13

Last Posted Date: 2016-02-03

Lead Sponsor: University of Rochester

Target Recruit Count: 40

Registration Number: NCT00861341

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)

Phase 2

Completed

Conditions: Alcohol Dependence
Depression

Interventions: Behavioral: Interpersonal Psychotherapy for Co-occurring Alcohol Dependence and Major Depression (IPT-ADMD)
Behavioral: Treatment as Usual

First Posted Date: 2009-02-26

Last Posted Date: 2013-07-16

Lead Sponsor: University of Rochester

Target Recruit Count: 91

Registration Number: NCT00851669

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Exercise for Breast Cancer Patients (EXCAP)

Not Applicable

Completed

Conditions: Fatigue

Interventions: Behavioral: Progressive walking and resistance exercise treatment
Behavioral: Exercise

First Posted Date: 2009-02-26

Last Posted Date: 2020-02-17

Lead Sponsor: University of Rochester

Target Recruit Count: 114

Registration Number: NCT00851812

Locations: 🇺🇸
James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, United States

Atomoxetine, Placebo and Parent Management Training in Autism

Phase 4

Completed

Conditions: Attention Deficit Hyperactivity Disorder
Autism
Pervasive Development Disorder
Asperger's Disorder

Interventions: Drug: atomoxetine
Drug: Placebo
Behavioral: Parent Management Training

First Posted Date: 2009-02-16

Last Posted Date: 2016-02-04

Lead Sponsor: University of Rochester

Target Recruit Count: 128

Registration Number: NCT00844753

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Women's Depression Treatment Study

Phase 2

Completed

Conditions: Depression

Interventions: Behavioral: Interpersonal Psychotherapy-Trauma in Community Settings
Behavioral: Treatment as Usual

First Posted Date: 2009-02-13

Last Posted Date: 2014-01-09

Lead Sponsor: University of Rochester

Target Recruit Count: 162

Registration Number: NCT00843700

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy